Actym Therapeutics, Inc.

Actym Therapeutics, Inc.

Edit info

  • Founded: 2017
  • Location: Berkeley, California
  • Employee range: 1-50
  • Clinical stage: Clin0
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: ACTM-838
  • Funding: 10 - 100M


www.actymthera.com

linkedin.com

job board


Drug notes:

2 undisclosed programs RD oncology

About:

Actym Therapeutics is developing innovative cancer treatments. Their research centers on manipulating the tumor microenvironment (TME) to enhance the body's immune response against cancer. Actym's unique approach involves a genetically modified bacterial vehicle designed to deliver multiple therapeutic payloads directly to the tumor site. By targeting specific metabolites within the TME, this bacterial vehicle selectively accumulates in tumors, amplifying its therapeutic effect and stimulating an immune response. This novel drug modality has the potential to revolutionize cancer treatment by overcoming the challenges of the complex tumor microenvironment.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com